As of February 2015, OxyElite Pro is no longer available for purchase in retail or online stores. The FDA recently ordered USPLabs to destroy the estimated $22 million of remaining warehouse stock.
OxyElite Pro was recalled from the market after it was linked to at least 100 cases of acute liver failure and hepatitis, including one death and several cases requiring liver transplants.
USPLabs first came under investigation in 2013 when it was discovered that a stimulant used in the supplement -dimethylamylamine- was linked to high blood pressure, heart attacks, seizures, psychiatric disorders and death. The Texas company responded by replacing it with aegeline, but did not provide the FDA with proof of its safety.
Persons in possession of OxyElite Pro or the company's VERSA-1 are advised by the FDA to stop taking the supplement and destroy any remaining quantities.